Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Intangibles: 2010-2025

Historic Intangibles for Sunshine Biopharma (SBFM) over the last 4 years, with Sep 2025 value amounting to $2.1 million.

  • Sunshine Biopharma's Intangibles fell 30.32% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 30.32%. This contributed to the annual value of $3.1 million for FY2024, which is 117.33% up from last year.
  • Per Sunshine Biopharma's latest filing, its Intangibles stood at $2.1 million for Q3 2025, which was down 20.76% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Intangibles peaked at $3.3 million during Q1 2025, and registered a low of $776,856 during Q4 2022.
  • For the 3-year period, Sunshine Biopharma's Intangibles averaged around $2.2 million, with its median value being $2.1 million (2024).
  • As far as peak fluctuations go, Sunshine Biopharma's Intangibles surged by 143.58% in 2024, and later plummeted by 30.32% in 2025.
  • Quarterly analysis of 4 years shows Sunshine Biopharma's Intangibles stood at $776,856 in 2022, then surged by 85.91% to $1.4 million in 2023, then skyrocketed by 117.33% to $3.1 million in 2024, then crashed by 30.32% to $2.1 million in 2025.
  • Its Intangibles stands at $2.1 million for Q3 2025, versus $2.7 million for Q2 2025 and $3.3 million for Q1 2025.